# CardiaTec Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cardiatec-biosciences

- Industry: Biotechnology
- Headquarters: Cambridge, UK
- Website: www.cardiatec.ai
- Total disclosed funding: $6.4M
- Latest round: Seed (Jun 7, 2024)
- Investors on record: 4

## About

Founded in 2021 by Namshik Han (CTO), Raphael Peralta (CEO), and Thelma Zablocki (COO), and based in Cambridge, UK, CardiaTec Biosciences LTD is a target discovery platform developer that uses artificial intelligence to examine human multi-omic cardiovascular data. In September 2024, CardiaTec Biosciences LTD raised USD 6.5 million in seed funding led by new investor Montage Ventures, with participation from another new investor Continuum Health Ventures. Returning investors Apex Ventures, Laidlaw Scholars Ventures and individual investors also participated in the round.

CardiaTec uses its patented target discovery platform, which employs artificial intelligence to comprehend large amounts of multi-omic cardiovascular data, explore target drug interactions and understand relationships between various levels of biology, including gene variation, and methylation, expression, etc. The firm explores novel aspects of patient stratification to define patient groups most compatible with the firm’s discovered targets and drugs to increase therapeutic outcomes to suit the varying needs of patients instead of offering a uniform medicine for all.

The company intends to use the September 2024 funding to accelerate its growth for cardiovascular disease drugs.

## Funding rounds

- Seed, Jun 7, 2024, $6.4M — Montage Ventures, Apex Ventures, Laidlaw Scholars Ventures, Continuum Health Ventures

## Investors

- Montage Ventures (https://capitalatlas.ai/funds/montage-ventures) — Seed
- Apex Ventures (https://capitalatlas.ai/funds/apex-ventures) — Seed
- Laidlaw Scholars Ventures (https://capitalatlas.ai/funds/laidlaw-scholars-ventures) — Seed
- Continuum Health Ventures (https://capitalatlas.ai/funds/continuum-health-ventures) — Seed